In response to the SARS-COV-2 pandemic, many changes in the delivery of medical care changed to minimise the risk to both staff and patients through introducing physical distancing measures. Typically, all women during pregnancy will undergo an oral glucose tolerance test (OGTT) between 24-28 weeks' gestation to determine whether their pregnancy has been complicated by gestational diabetes (GDM). However, the OGTT test requires 3 blood samples to be collected over a period of 2 hours within a pathology centre. With the introduction of physical distancing measures to minimise the risk to both staff and patients of contracting COVID-19, the screening protocol for GDM was modified to minimise the number of women undergoing an OGTT. Prior to the SARS-COV-2 pandemic OGTT screening resulted in ~13% of pregnant women being diagnosed with GDM.This research project will assess whether the implementation of a modified GDM screening program has impacted on the rates of pregnancies diagnosed with GDM, as well as the impact on pregnancy outcomes, such as induction of labour, gestation at birth, fetal macrosomia, caesarean section rates for failure to progress, birth trauma and neonatal hypoglycaemia. This information will assist in informing the ongoing use of a modified GDM screening program in maternity care at Monash Health following the SARS-COV-2 pandemic.
Obstetrics; Antenatal Care; Maternity; Gestational Diabetes; Diagnosis; Screening
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Obstetrics and Gynaceology
Top-up scholarship funding available
Monash Health Translation Precinct (Monash Medical Centre)